Sales Force Login   Speaker Login   Distributor Locator   Contact Us    

  
 
Home > Clinical Education > Reducing VAP/HAP Risk Factors > Published Studies and Articles
Clinical Support
  Symposia Presentations
Published Studies and Articles
Case Studies
Continuing Education
Professional Guidelines
Implementation Tools 
Education Tools 
Publish Your Results 
Related Organizations 
 
  Upcoming Events
Reducing VAP/HAP Risk Factors

Clinical Evaluation of the Effect of a Hydrogen Peroxide Mouth Rinse, Toothette-Plus® Swab Containing Sodium Bicarbonate, and a Water-Based Mouth Moisturizer on Oral Health in Medically Compromised Patients

Article Summary

 

Publication: Periodontal Insights

March 1999


Authors: William Carl, DMD, Carrie Daly, RN, MS, Sebastiano Andreana, DDS, MS, Sebastian Ciancio, DDS, Robert E. Cohen, DDS, PhD, Russell J. Nisengard, DDS, PhD


OBJECTIVE:

To assess the clinical efficacy of a hydrogen peroxide mouth rinse, sodium bicarbonate containing Toothette® Plus swab, and a water-based mouth moisturizer on oral health of patients undergoing chemotherapy for cancer.

STUDY DESIGN:

Double-blind, stratified, two-treatment, parallel trial involving 48 adult volunteers at two cancer treatment centers over a four-week period.

CONTROL:

Baking soda and water rinses or lemon glycerin solution.

RESULTS:

  • "Only 24% of patients in the Sage group showed tissue abnormalities compared to 44% of those in the control group."

  • Mucositis Evaluation - "To summarize, in percentages, the adverse change in mucositis was 3% in the Sage group and 15% in the control group."

  • Plaque Index - (Table 3)

  • Gingivitis Index - (Table 4)

  • Statistical Evaluation - "There was no significant difference between groups because the sample sizes differed and there was a wide variation within the subjects' responses. However, for almost all comparisons, results of evaluations using Sage products were better than those of the control group."

ADVERSE EFFECTS:

  • No significant product-related adverse effects, including staining of teeth, were observed in either group.

  • "The Sage group patients almost unanimously liked their product (34/35), whereas only 1 of 16 patients in the control group liked their product."

CONCLUSION/DISCUSSION:

  • "Patients felt the Perox-A-Mint® solution and Toothettes® were soothing, left a clean, fresh feeling in their mouth, and helped to reduce thick ropey saliva."

  • "This indicates that Sage 6000 also may be helpful in patients affected by xerostomia."

  • "Sage products significantly reduced the chemical or metallic taste in the mouth due to chemotherapy, helped improve appetite and decreased a feeling of nausea in most patients."

  • "The Sage 6000 kit can be recommended for safety and efficacy in patients undergoing chemotherapy and concomitant therapy."

This area of our website and its content is intended for healthcare professionals only.
 
Clinical Products | Clinical Education | Company | Careers | Privacy Policy | Newsroom | Contact Us | Home | 800-323-2220
© Sage Products, Inc. 1997-2007 · 3909 Three Oaks Rd, Cary, IL 60013